| Combination of | |
|---|---|
| Niacin | n/a |
| Lovastatin | Statin |
| Clinical data | |
| Pregnancy cat. | X(US) |
| Legal status | ℞-only (US) |
| Routes | Oral |
| Identifiers | |
| ATC code | C10BA01 |
| (what is this?) (verify) |
|
Niacin/lovastatin (trade names Advicor, Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of niacin and the statin drug lovastatin. The combination preparation is marketed by Abbott Laboratories
It was approved by the FDA on December 17, 2001.
The combination is available as tablets containing:.[1]
|
||||||||||||||||||||||||||||||||||||||||